Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.867
-0.019 (-2.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vor Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -112.46 | -117.86 | -92.09 | -68.9 | -43.34 | -10.84 | |
| Depreciation & Amortization | 3.56 | 3.49 | 2.53 | 1.43 | 0.61 | 0.09 | |
| Stock-Based Compensation | 10.03 | 13.36 | 10.7 | 4.32 | 1.34 | 0.17 | |
| Other Operating Activities | 2.84 | 0.07 | 3.57 | 3.19 | 0.78 | 0.58 | |
| Change in Accounts Payable | -1.27 | 2.85 | 1.11 | 0.41 | 5.82 | 1.21 | |
| Change in Other Net Operating Assets | -2.32 | -2.2 | -10.95 | -9.59 | -1.5 | -1.07 | |
| Operating Cash Flow | -99.62 | -100.29 | -85.14 | -69.14 | -36.29 | -9.86 | |
| Capital Expenditures | -0.27 | -1.07 | -8.46 | -3.89 | -4.16 | -0.75 | |
| Investment in Securities | 107.53 | 72.08 | -85.63 | -87.76 | - | - | |
| Investing Cash Flow | 107.26 | 71.01 | -94.09 | -91.65 | -4.16 | -0.75 | |
| Issuance of Common Stock | 0.46 | 4.84 | 117.14 | 189.75 | 0.26 | 0.01 | |
| Repurchase of Common Stock | -0.33 | -1.19 | - | - | - | - | |
| Other Financing Activities | - | -0.72 | - | -2.22 | - | - | |
| Financing Cash Flow | 0.13 | 2.94 | 117.14 | 232.91 | 82.53 | 17.7 | |
| Net Cash Flow | 7.77 | -26.35 | -62.1 | 72.12 | 42.07 | 7.1 | |
| Free Cash Flow | -99.89 | -101.36 | -93.61 | -73.04 | -40.45 | -10.6 | |
| Free Cash Flow Per Share | -1.47 | -1.51 | -2.37 | -2.18 | -189.34 | -92.23 | |
| Levered Free Cash Flow | -62.04 | -58.02 | -51.87 | -48.67 | -21.65 | -9.57 | |
| Unlevered Free Cash Flow | -62.04 | -58.02 | -51.87 | -48.67 | -21.65 | -9.19 | |
| Change in Net Working Capital | 1.61 | -4.97 | -1.76 | 7.39 | -7.66 | 2.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.